Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sipai Health Technology Co's Enterprise Value is HK$329 Mil.
Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-139 Mil. Therefore, Sipai Health Technology Co's EV-to-EBIT ratio for today is -2.36.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Sipai Health Technology Co (HKSE:00314) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Sipai Health Technology Co's EV-to-EBIT for today is
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-139 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Sipai Health Technology Co's EV-to-EBITDA for today is:
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-110 Mil.
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was HK$2,274 Mil.
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was HK$8 Mil.
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sipai Health Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co Enterprise Value Related Terms
Sipai Health Technology Co Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:00314 vs MCK, COR, CAH: Enterprise Value Comparison
For the Medical Distribution subindustry, Sipai Health Technology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sipai Health Technology Co Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sipai Health Technology Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Sipai Health Technology Co's Enterprise Value falls into.
Sipai Health Technology Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Sipai Health Technology Co's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sipai Health Technology Co (HKSE:00314) has a Enterprise Value of HK$329 Mil as of Aug. 20, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sipai Health Technology Co and its competitors.
Is Sipai Health Technology Co's Enterprise Value too high?
Sipai Health Technology Co's current Enterprise Value is HK$329 Mil. Overall, Sipai Health Technology Co has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sipai Health Technology Co's Enterprise Value compare to MCK and COR?
Sipai Health Technology Co's Enterprise Value of HK$329 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Sipai Health Technology Co and its competitors. Sipai Health Technology Co's current Enterprise Value is HK$329 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sipai Health Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Sipai Health Technology Co (HKSE:00314) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.39, compared to a current price of HK$1.50 — trading 37.4% below its estimated fair value. The current Enterprise Value is HK$329 Mil. Sipai Health Technology Co's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Sipai Health Technology Co (HKSE:00314), the current Enterprise Value is HK$329 Mil as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sipai Health Technology Co (HKSE:00314) Overvalued in 2026?
Based on GuruFocus' analysis, Sipai Health Technology Co stock appears to be undervalued.
The current stock price of HK$1.50 is trading 37.4% below its estimated GF Value™ of HK$2.39.
GuruFocus considers Sipai Health Technology Co to be Possible Value Trap.
Key valuation signals for HKSE:00314:
Enterprise Value: HK$329 Mil
GF Value™: HK$2.39 vs. price of HK$1.50 (37.4% below fair value)
No single metric tells the full story. See the HKSE:00314 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sipai Health Technology Co Ltd is a medical technology and health management company in China. The company has three reportable operating segments: Specialty Pharmacy Business - engaged in the operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Commercial Insurance Services Business - rendering insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. The company generates key revenue from the Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
64GF Score
Get the complete analysis for HKSE:00314
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00314 has been successfully added to your 
